1 Canadian Research and Development Centre for Probiotics, Microbiology & Immunology, and Surgery, University of Western Ontario, Room F3-106, P.O. Box 5777, STN B, London, N6A 4V2 Ontario, Canada.
2 Yoba for Life foundation, Hunzestraat 133-A, 1079 WB Amsterdam, the Netherlands.
Benef Microbes. 2018 Sep 18;9(5):707-715. doi: 10.3920/BM2018.0015. Epub 2018 May 25.
The rapid rise in microbiome and probiotic science has led to estimates of product creation and sales exceeding $50 billion within five years. However, many people do not have access to affordable products, and regulatory agencies have stifled progress. The objective of a discussion group at the 2017 meeting of the International Scientific Association for Probiotics and Prebiotics was to identify mechanisms to confer the benefits of probiotics to a larger portion of the world's population. Three initiatives, built around fermented food, were discussed with different methods of targeting populations that face enormous challenges of malnutrition, infectious disease, poverty and violent conflict. As new candidate probiotic strains emerge, and the market diversifies towards more personalised interventions, manufacturing processes will need to evolve. Information dissemination through scientific channels and social media is projected to provide consumers and healthcare providers with rapid access to clinical results, and to identify the nearest location of sites making new and affordable probiotic food and supplements. This rapid translation of science to individual well-being will not only expand the beneficiaries of probiotics, but also fuel new social enterprises and economic business models.
微生物组和益生菌科学的迅速发展，预计在五年内将产品的创造和销售规模超过 500 亿美元。然而，许多人无法获得负担得起的产品，监管机构也阻碍了这一进程。在 2017 年国际益生菌和益生元科学协会会议上的一个讨论小组的目标是确定将益生菌的益处赋予世界更多人口的机制。围绕发酵食品，讨论了三个倡议，探讨了针对营养不良、传染病、贫困和暴力冲突等巨大挑战的人群的不同方法。随着新的候选益生菌菌株的出现，以及市场向更加个性化干预措施的多样化，制造工艺将需要发展。通过科学渠道和社交媒体传播信息，预计将为消费者和医疗保健提供者提供快速获取临床结果的途径，并确定生产新的、负担得起的益生菌食品和补充剂的最近地点。这种将科学迅速转化为个人健康的做法不仅将扩大益生菌的受益者，还将为新的社会企业和经济商业模式提供动力。
